Mineralys Therapeutics, Inc. (MLYS)
20.53
+0.23
(+1.13%)
USD |
NASDAQ |
Oct 19, 14:19
Mineralys Therapeutics Price : 20.53 for Oct. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 21.60 | 21.60 | 20.12 | 20.30 | 1.181M |
| Oct 15, 2026 | 21.04 | 21.83 | 20.82 | 21.64 | 1.094M |
| Oct 14, 2026 | 20.74 | 22.23 | 20.61 | 20.76 | 1.160M |
| Oct 13, 2026 | 22.04 | 22.82 | 20.41 | 21.00 | 3.346M |
| Oct 12, 2026 | 22.90 | 23.10 | 22.16 | 22.23 | 1.003M |
| Oct 09, 2026 | 22.49 | 23.68 | 22.36 | 23.37 | 895314.0 |
| Oct 08, 2026 | 22.24 | 22.39 | 21.46 | 22.38 | 2.245M |
| Oct 07, 2026 | 21.78 | 22.44 | 21.48 | 22.09 | 989115.0 |
| Oct 06, 2026 | 23.54 | 23.54 | 21.88 | 21.95 | 1.216M |
| Oct 05, 2026 | 23.98 | 24.00 | 22.97 | 23.30 | 1.079M |
| Oct 02, 2026 | 24.01 | 24.34 | 23.55 | 23.63 | 928299.0 |
| Oct 01, 2026 | 25.13 | 25.34 | 23.58 | 23.72 | 1.655M |
| Sep 30, 2026 | 24.48 | 25.89 | 24.44 | 25.13 | 2.052M |
| Sep 29, 2026 | 25.39 | 25.78 | 24.43 | 24.48 | 1.720M |
| Sep 28, 2026 | 25.46 | 25.95 | 24.92 | 25.63 | 1.701M |
| Sep 25, 2026 | 26.55 | 26.70 | 25.21 | 25.86 | 1.193M |
| Sep 24, 2026 | 26.77 | 27.07 | 25.83 | 26.59 | 895397.0 |
| Sep 23, 2026 | 29.36 | 29.83 | 26.62 | 26.89 | 1.479M |
| Sep 22, 2026 | 28.63 | 29.55 | 28.37 | 29.40 | 849455.0 |
| Sep 21, 2026 | 28.19 | 28.44 | 27.90 | 28.31 | 701839.0 |
| Sep 18, 2026 | 27.77 | 28.13 | 27.38 | 28.02 | 3.787M |
| Sep 17, 2026 | 27.95 | 29.52 | 27.93 | 27.98 | 1.142M |
| Sep 16, 2026 | 28.98 | 29.08 | 27.33 | 27.54 | 1.415M |
| Sep 15, 2026 | 28.58 | 28.98 | 27.55 | 28.91 | 1.781M |
| Sep 14, 2026 | 28.14 | 29.61 | 27.89 | 28.95 | 1.193M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 56.60 |
| Oncolytics Biotech, Inc. | 0.5033 |
| Sangamo Therapeutics, Inc. | 0.1102 |
| Sarepta Therapeutics, Inc. | 17.71 |
| Anixa Biosciences, Inc. | 2.66 |
Price Related Metrics
| PEG Ratio | -0.2546 |
| Price to Book Value | 3.292 |
| Earnings Yield | -20.67% |
| Market Cap | 1.814B |
| PEGY Ratio | -0.2546 |